Patent ID: 9534258
Date: 2017-01-03
CPC Classifications: A61P,C12Q,G16H

Claim:
1. (Allowed) A kit for determining prognosis of melanoma cancer, comprising: forward and reverse oligonucleotide primers for each of the genes: a labeled oligonucleotide probe for each of said genes; for MFGE8, said forward primer consisting of the sequence of SEQ ID NO.11, said reverse primer consisting of the sequence of SEQ ID NO.12; for IDH1, said forward primer consisting of the sequence of SEQ ID NO.13, said reverse primer consisting of the sequence of SEQ ID NO.14; for PILRA, said forward primer consisting of the sequence of SEQ ID NO.3, said reverse primer consisting of the sequence of SEQ ID NO.4; for HLA-E, said forward probe consisting of the sequence of SEQ ID NO.5, said reverse primer consisting of the sequence of SEQ ID No.6; and for TXNDC5, said forward primer consisting of the sequence of SEQ ID NO.1, said reverse primer consisting of the sequence of SEQ ID NO.2.